Penumbra, Inc. (PEN) Financials

PEN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.9 billion 424.6 million
Dec. 31, 2025 1.8 billion 398.9 million
Sept. 30, 2025 1.7 billion 385.7 million
June 30, 2025 1.7 billion 380.9 million

PEN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 73.3 million 14.6 million
Dec. 31, 2025 68.1 million 15.3 million
Sept. 30, 2025 42.0 million 15.9 million
June 30, 2025 29.4 million 14.2 million

PEN Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 32.6 million
Dec. 31, 2025 -130.3 million
Sept. 30, 2025 45.9 million
June 30, 2025 45.3 million

PEN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 241.3 million 199.6 million 216.2 million
Dec. 31, 2025 186.9 million 203.5 million 219.7 million
Sept. 30, 2025 470.3 million 21.2 million 201.5 million
June 30, 2025 424.6 million 21.8 million 220.5 million

PEN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 39.5 million
Dec. 31, 2025 39.4 million
Sept. 30, 2025 39.3 million
June 30, 2025 39.2 million

PEN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 13.7 million 22.4 million 192.8 million -
Dec. 31, 2025 18.4 million 21.8 million 181.1 million -
Sept. 30, 2025 16.2 million 22.7 million 168.9 million -
June 30, 2025 15.6 million 23.2 million 160.0 million -

PEN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 374.8 million 121.3 million
Dec. 31, 2025 385.4 million 123.3 million
Sept. 30, 2025 354.7 million 114.3 million
June 30, 2025 339.5 million 115.4 million

PEN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PEN

Price: $318.18

52 week price:
221.26
362.41

Earnings Per Share: 4.35 USD

P/E Ratio: 74.08

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 268800

Ebitda: 1.8 million

Market Capitalization: 12.6 billion

Links: